Brief: Relief And Acer Therapeutics Submit Of New Drug Application To FDA For Acer-001 For Treatment Of Urea Cycle Disorders

MindMaze Therapeutics Holding SA

09/08/2021 06:03

Aug 9 (Reuters) - RELIEF THERAPEUTICS HOLDING SA  RLFB.S :
    * ACER THERAPEUTICS AND RELIEF THERAPEUTICS ANNOUNCE
SUBMISSION OF
A NEW DRUG APPLICATION TO THE U.S. FDA FOR ACER-001 FOR
TREATMENT OF UREA CYCLE DISORDERS

Source text for Eikon:  ID:nEQ4kZSJMa 
Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))